The Peptide Therapeutics Symposium was established in 2005 as an annual scientific meeting that brings together world leaders in peptide research from academia and the biopharmaceutical industries. The meeting’s focus is advances in core technology pertinent to peptide-based drug discovery and therapeutic candidate development. The unique format provides an intense set of lectures through a period of just over twenty-four hours, starting midday Thursday and concluding end of day Friday.
Please join us for the 13th Annual Peptide Therapeutics Symposium taking place October 25th and 26th, 2018 at the Salk Institute for Biological Studies in La Jolla, California. This year’s Symposium continues the tradition of excellence in presenting ‘best of the best’ advances in the field of peptide therapeutics.
Registration is limited given the finite capacity of the auditorium. The last two years we were unable to accommodate the full demand and we expect that to be the case this year. We encourage you to inspect the program and register early.
We look forward to seeing you at this year’s event.
Richard DiMarchi, PhD
Stéphane Bolduc – CHU de Québec – Université Laval Research Center
Marcello Costa – Flinders University
Warren Foster – University of California, San Diego
Andrew Horne – University of Edinburgh
K. Joseph Hurt – University of Colorado
Ursula Kaiser – Brigham and Women’s Hospital, Harvard Medical School
Sarah Marshall – Monash University
Kathryn Meier – Washington State University
Victor Navarro – Brigham and Women’s Hospital, Harvard Medical School
Willis Samson – Saint Louis University, School of Medicine
John Taylor – Kansas University Medical Center
Suraj Unniappan – University of Saskatchewan
Henrique Veiga-Fernandes – Champalimaud Foundation
Meet the 2016 Recipients
October 25-26, 2018
The Salk Institute